xCures is a biotechnology and healthcare startup, established in 2018, with a slogan of "Right Patient, Right Treatment, Right Time." The company focuses on healthcare data management, aiming to achieve data completeness and provide real-time data access. xCures gathers and standardizes detailed medical records from various healthcare sources, including direct retrieval from US institutions, patient portals, and electronic health exchanges. Utilizing Natural Language Processing, the collected data is digitized, organized, and examined to identify features, resulting in a comprehensive longitudinal patient journey that covers everything from genomics to social determinants of health. The company has processed over 140 million records from thousands of different medical practices and implemented its technology for a significant number of patients. All collected data elements are thoroughly annotated in a central Electronic Data Capture (EDC) system to ensure standardization and ongoing accuracy. The company offers clinically actionable, real-time insights through a range of tools and products to support the care of patients, providers, and partners. The latest investment in xCures was a Convertible Note investment at 01 December 2023, and the investor was HealthTech Capital. For further information, interested parties can contact [email protected] or visit http://www.xcures.com.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Convertible Note | Unknown | 1 | 01 Dec 2023 | |
Series A | Unknown | 2 | 11 Apr 2022 | |
Series A | $125.00K | 1 | 06 Nov 2021 | |
Series A | $12.69M | 5 | Boehringer Ingelheim Venture Fund | 23 Jun 2021 |
Convertible Note | $150.00K | - | 21 Apr 2021 |
No recent news or press coverage available for xCures.